# Metabolic Syndrome Management Protocol

**Version:** 1.0
**Expand Health Cape Town**
**Updated:** December 2025

---

## Definition & Diagnostic Criteria

Metabolic syndrome is diagnosed when a patient presents with **3 or more** of the following:

- **Waist circumference:** >102 cm (40 inches) for men, >88 cm (35 inches) for women
- **Triglycerides:** ≥150 mg/dL (1.7 mmol/L)
- **HDL cholesterol:** <40 mg/dL (1.0 mmol/L) for men, <50 mg/dL (1.3 mmol/L) for women
- **Blood pressure:** ≥130/85 mmHg or on antihypertensive medication
- **Fasting glucose:** ≥100 mg/dL (5.6 mmol/L) or on glucose-lowering medication

---

## Pathophysiology & Root Causes

Metabolic syndrome represents a cluster of interconnected metabolic disturbances driven by:

1. **Insulin Resistance:** Cells become less responsive to insulin, leading to elevated blood glucose and compensatory hyperinsulinemia
2. **Chronic Inflammation:** Elevated inflammatory markers (hsCRP, IL-6) contribute to vascular damage
3. **Oxidative Stress:** Mitochondrial dysfunction and reduced antioxidant capacity
4. **Visceral Adiposity:** Central fat accumulation produces inflammatory adipokines
5. **Endothelial Dysfunction:** Impaired nitric oxide production and vascular health

---

## Clinical Assessment

### Essential Labs
- Fasting glucose and HbA1c
- Lipid panel (total cholesterol, LDL, HDL, triglycerides)
- hsCRP (inflammatory marker)
- Fasting insulin (to calculate HOMA-IR)
- Liver function (ALT, AST) - assess for NAFLD
- Vitamin D
- Thyroid panel (TSH, Free T3, Free T4)

### Advanced Diagnostics (Optional)
- Apolipoprotein B (ApoB)
- Lipoprotein(a) - Lp(a)
- Uric acid
- Homocysteine
- Omega-3 index
- Organic acid testing (mitochondrial function)
- DEXA scan (body composition)

### Cardiovascular Risk Scoring
- Calculate 10-year cardiovascular risk (Framingham, ASCVD calculator)
- Assess family history
- Evaluate lifestyle risk factors

---

## Evidence-Based Intervention Strategy

### Phase 1: Foundation (Weeks 0-4)

**Goal:** Establish metabolic foundation through lifestyle and basic supplementation

#### Dietary Approach
**Mediterranean-Style Low-Glycemic Nutrition:**
- Eliminate refined carbohydrates and added sugars
- Focus on whole foods: vegetables, lean proteins, healthy fats
- Include omega-3 rich fish 2-3x per week
- Target fiber intake: 30-40g daily
- Implement time-restricted eating (14-16 hour overnight fast)
- Limit alcohol to ≤2 drinks per week

**Macronutrient Targets:**
- Protein: 1.6-2.0g per kg ideal body weight
- Healthy fats: 25-35% of calories (emphasis on monounsaturated and omega-3)
- Complex carbohydrates: 40-50% of calories, low glycemic index

#### Core Supplement Protocol

**Insulin Sensitivity & Glucose Control:**
- **Berberine:** 500mg twice daily with meals
  - Evidence: Reduces HbA1c by 0.5-0.7%, improves insulin sensitivity via AMPK activation
  - Contraindications: Pregnancy, breastfeeding
  - Monitor: May cause GI upset; take with food

- **Chromium Picolinate:** 200-400mcg daily
  - Evidence: Supports insulin receptor function and glucose metabolism

- **Alpha-Lipoic Acid (ALA):** 600mg daily
  - Evidence: Improves insulin sensitivity, reduces oxidative stress

**Cardiovascular & Lipid Support:**
- **Omega-3 (EPA/DHA):** 2000-3000mg daily
  - Evidence: Reduces triglycerides 20-30%, anti-inflammatory
  - Target ratio: Higher EPA for metabolic benefits

- **CoQ10:** 100-200mg daily
  - Evidence: Supports mitochondrial function, cardiovascular health
  - Important if planning statin therapy

**Vitamin & Mineral Optimization:**
- **Vitamin D3:** 4000-5000 IU daily (adjust based on levels, target 50-80 ng/mL)
- **Magnesium Glycinate:** 400-600mg before bed
  - Evidence: Improves insulin sensitivity, supports sleep

**Mitochondrial Support:**
- **L-Carnitine:** 1500-2000mg daily
  - Evidence: Improves fat metabolism, cellular energy

- **PQQ (Pyrroloquinoline Quinone):** 20mg daily
  - Evidence: Supports mitochondrial biogenesis

#### Exercise Protocol

**Weeks 1-2: Foundation**
- Daily 20-30 minute walk (post-meal optimal for glucose control)
- Goal: Establish habit, improve glucose disposal

**Weeks 3-4: Progressive Intensity**
- Increase to 30-40 minutes daily moderate activity
- Add 2x per week resistance training (20-30 minutes)
- Focus: Major muscle groups, progressive overload
- Acceptable formats: Bodyweight, dumbbells, resistance bands

#### Lifestyle Optimization
- **Sleep:** Target 7-8 hours nightly
  - Consistent bed/wake times
  - Cool, dark room (16-19°C)
  - No screens 60 minutes before bed

- **Stress Management:**
  - Daily breathwork or meditation (10 minutes)
  - Regular sauna sessions (see Expand Health protocols)
  - Consider nervous system regulation technologies (PEMF, HeartMath)

---

### Phase 2: Advanced Therapies (Weeks 4-12)

**Goal:** Accelerate metabolic reversal with Expand Health clinic therapies

#### Hyperbaric Oxygen Therapy (HBOT)

**Protocol:** 20 sessions over 6-10 weeks (2-3x per week)

**Rationale:**
- Improves insulin sensitivity through enhanced cellular oxygenation
- Reduces systemic inflammation
- Supports mitochondrial function and ATP production
- Enhances endothelial function and vascular health

**Session Details:**
- Duration: 60-90 minutes
- Pressure: 1.5-2.0 ATA
- Timing: Morning sessions optimal (fasted state)

**Expected Outcomes:**
- Energy improvement within 3-5 sessions
- Better glucose regulation
- Reduced inflammation markers
- Enhanced cognitive function

**Patient Preparation:**
- No caffeine 2 hours before session
- Light meal 2-3 hours prior
- Comfortable clothing (100% cotton recommended)

**Evidence:**
- Studies show improved insulin sensitivity and reduced inflammatory markers
- Safe adjunct therapy for metabolic syndrome

#### IV Nutrient Therapy

**Phase 2A - Weeks 4-7: Mitochondrial Restoration**

**Weekly IV Protocol:**
- Myers Cocktail Base (B-complex, Vitamin C, Magnesium, Calcium)
- Add: Glutathione 1200-2000mg (master antioxidant, detoxification)
- Add: L-Carnitine 1000mg (fat metabolism, energy)
- Purpose: Nutrient repletion, oxidative stress reduction

**Phase 2B - Weeks 8-11: Cellular Repair & Longevity**

**NAD+ IV Therapy:**
- NAD+ 250-500mg (titrate based on tolerance)
- Frequency: Weekly for 4 weeks, then every 2-4 weeks maintenance
- Purpose: Cellular energy, DNA repair, metabolic optimization, longevity pathway activation

**Expected Outcomes:**
- Significant energy improvement
- Enhanced mental clarity and focus
- Improved metabolic markers
- Better sleep quality

**Monitoring:**
- Pre/post energy levels (1-10 scale)
- Symptom tracking
- Any adverse reactions (rare: nausea, flushing during infusion)

#### Red Light Therapy (Photobiomodulation)

**Protocol:** Daily or 5x per week

**Session Details:**
- Wavelengths: 660nm (red) + 850nm (near-infrared)
- Duration: 15-20 minutes
- Timing: Morning or post-exercise optimal
- Target: Full body panel

**Benefits for Metabolic Syndrome:**
- Mitochondrial ATP production enhancement
- Improved insulin sensitivity
- Reduction in systemic inflammation
- Enhanced muscle recovery and performance
- Mood and sleep quality improvement

**Home Use Option:**
- Can recommend specific devices for home therapy
- Ensure adequate power density and wavelength specifications

#### Sauna Therapy

**Protocol:** 3-5x per week

**Benefits:**
- Cardiovascular conditioning
- Improved insulin sensitivity
- Heat shock protein activation (cellular repair)
- Detoxification support
- Stress reduction

**Session Details:**
- Duration: 20-30 minutes
- Temperature: 70-85°C for traditional, 50-60°C for infrared
- Hydration: Drink 500mL water before and after
- Consider sauna + cold plunge circuit for enhanced benefits

#### Optional: Peptide Therapy (After 4-Week Foundation)

**Consider if patient demonstrates dietary compliance and appropriate candidacy**

**CJC-1295 / Ipamorelin Combination:**
- Purpose: Growth hormone optimization for fat loss, muscle gain, metabolic support
- Protocol: Subcutaneous injection, 5 days on / 2 days off
- Dosing: Conservative start, titrate based on IGF-1 levels
- Monitoring: Baseline IGF-1, recheck at weeks 4, 8, 12

**Patient Selection Criteria:**
- No contraindications (active malignancy, uncontrolled diabetes)
- Demonstrated compliance with lifestyle foundation
- Realistic expectations discussed
- Budget appropriate

**Timeline:** Reassess at 4-week mark after foundation established

---

### Phase 3: Optimization & Maintenance (Weeks 12+)

**Goal:** Sustain improvements and transition to maintenance

#### Lab Retesting Schedule
- **Week 6:** Fasting glucose, insulin (assess early intervention effect)
- **Week 12:** Full metabolic panel - lipids, HbA1c, hsCRP, liver function
- **Week 24:** Comprehensive reassessment

#### Therapy Transition
- Reduce HBOT to maintenance (1x per week or monthly blocks)
- IV therapy as needed (monthly or quarterly NAD+ boosters)
- Continue red light therapy (home or clinic)
- Maintain sauna routine

#### Supplement Adjustment
- Continue core supplements (berberine, omega-3, vitamin D, magnesium)
- Adjust based on lab improvements
- Consider cycling certain supplements

#### Lifestyle Maintenance
- Maintain dietary patterns (80/20 rule acceptable)
- Continue regular exercise (150+ min/week moderate + 2-3x resistance)
- Preserve stress management practices
- Annual comprehensive health assessments

---

## Expected Outcomes & Success Metrics

### 4-Week Targets
- **Energy:** 30-50% subjective improvement
- **Weight:** 2-4 kg loss (primarily visceral fat)
- **Fasting glucose:** Decrease 10-20 mg/dL
- **Waist circumference:** -3 to -5 cm
- **Sleep quality:** Noticeable improvement
- **Exercise capacity:** Improved endurance and recovery

### 12-Week Targets
- **HbA1c:** Decrease to <5.7% (prediabetes reversal goal)
- **LDL cholesterol:** Decrease 20-30% (target <130 mg/dL, ideally <100 mg/dL)
- **HDL cholesterol:** Increase 10-20% (target >40 mg/dL men, >50 mg/dL women)
- **Triglycerides:** Decrease 30-50% (target <150 mg/dL)
- **Weight:** 5-10 kg loss
- **Blood pressure:** Normalize (<130/85 mmHg)
- **hsCRP:** Decrease to <1.0 mg/L (low cardiovascular risk)
- **Energy & Quality of Life:** Sustained significant improvement

### 24-Week Targets
- **Metabolic syndrome resolution:** Meet <3 diagnostic criteria
- **Cardiovascular risk:** Reduction to low-risk category
- **Body composition:** Healthy body fat percentage, preserved lean mass
- **Medication reduction:** Potential reduction in BP or glucose medications (physician-guided)
- **Lifestyle integration:** Sustainable habits maintained independently

---

## Patient Education & Empowerment

### Key Concepts to Explain

**Why This Matters:**
- Metabolic syndrome significantly increases risk of type 2 diabetes, heart disease, stroke
- Early intervention can reverse the syndrome and prevent disease progression
- Small, consistent changes create powerful cumulative effects

**The Multi-System Approach:**
- No single intervention reverses metabolic syndrome
- Nutrition, movement, stress, sleep, and targeted therapies work synergistically
- Each intervention addresses different underlying mechanisms

**Timeline & Expectations:**
- Initial improvements (energy, mood) within 2-4 weeks
- Metabolic changes (labs) take 6-12 weeks
- Full reversal typically 6-12 months with compliance
- Maintenance is lifelong, but becomes easier as habits solidify

### Tools & Resources
- Food tracking app recommendations (MyFitnessPal, Cronometer)
- Exercise demonstration videos or personal training referral
- Progress tracking templates (weekly weigh-ins, measurements, energy logs)
- Educational materials on metabolic syndrome (videos, articles)
- Support community access (if available)

---

## Clinical Decision Tree

```
Patient Presents with Metabolic Syndrome
↓
Assess Severity & Risk
↓
Low-Moderate Risk → Start Phase 1 (Foundation)
  ↓
  Week 4 Assessment
    ↓
    Good Adherence + Some Improvement → Add Phase 2 Therapies (HBOT, IVs)
    Poor Adherence → Address Barriers, Extend Phase 1
    No Improvement → Advanced Labs, Consider Medications
↓
High Risk (CVD >20%, HbA1c >6.5%) → Immediate Medical Intervention
  ↓
  Consider Medications (Metformin, Statin)
  + Aggressive Lifestyle + Phase 2 Therapies Simultaneously
  + Close Monitoring
```

---

## Safety Considerations & Contraindications

### Berberine
- Avoid in pregnancy/breastfeeding
- May interact with diabetes medications (risk of hypoglycemia)
- GI upset common initially (take with food)

### HBOT
- Contraindications: Untreated pneumothorax, certain chemotherapy agents
- Caution: Severe COPD, pregnancy, recent ear surgery
- Side effects (rare): Ear barotrauma, temporary vision changes

### NAD+ IV
- May cause flushing, nausea during infusion (slow rate if occurs)
- Generally well-tolerated
- Avoid in pregnancy

### Exercise
- Cardiac clearance if high cardiovascular risk
- Start conservatively if sedentary
- Monitor for chest pain, severe shortness of breath

---

## When to Refer or Escalate

- **No improvement after 12 weeks** despite good adherence → Consider endocrinology referral, advanced testing
- **HbA1c >7.0%** or fasting glucose >140 mg/dL → Likely needs medication in addition to lifestyle
- **Cardiovascular symptoms** (chest pain, severe shortness of breath) → Cardiology referral
- **Severe hypertension** (>160/100) → May need immediate medication
- **Depression or severe stress** impacting compliance → Mental health support
- **Complex medical history** or multiple medications → Collaborate with primary physician

---

## Evidence Base

**Key References:**

1. Berberine for metabolic syndrome: Meta-analysis showing HbA1c reduction 0.5-0.7%, triglyceride reduction 20-30% (Diabetes Care 2015)

2. Omega-3 for cardiovascular risk: Reduction in triglycerides and inflammation (JAMA 2019)

3. Time-restricted eating for metabolic syndrome: Improved insulin sensitivity and weight loss (Cell Metabolism 2019)

4. Hyperbaric oxygen for metabolic health: Improved glucose metabolism and reduced inflammation (Diabetes Technology & Therapeutics 2017)

5. NAD+ for metabolic function: Enhanced mitochondrial function and metabolic markers (Science 2016)

6. Mediterranean diet for metabolic syndrome: Superior outcomes vs low-fat diet (PREDIMED Study, NEJM 2018)

7. Red light therapy for insulin sensitivity: Improved glucose metabolism (Lasers in Medical Science 2020)

---

## Cost Considerations & Patient Affordability

**Phase 1 (Foundation): Low Cost**
- Supplements: ~R2000-3000/month
- Lifestyle modifications: Free or minimal cost
- Labs: R2000-5000 (depends on insurance)

**Phase 2 (Advanced Therapies): Investment Phase**
- HBOT: R1500-2500 per session × 20 = R30,000-50,000
- IV Therapy: R1500-3500 per session × 8-12 = R12,000-42,000
- Red light, sauna: Included in membership or R500-800/session
- **Total Phase 2: R50,000-100,000 over 8-12 weeks**

**Phase 3 (Maintenance): Moderate Cost**
- Supplements: R1500-2000/month
- Periodic IVs or HBOT: R3000-6000/month
- Labs: R2000-3000 quarterly

**Membership Options:**
- May offer better value for ongoing maintenance
- Typical: R5000-15,000/month depending on tier

**ROI for Patient:**
- Prevention of diabetes, heart disease, medications
- Improved quality of life, energy, longevity
- Reduced long-term healthcare costs

---

## Doctor's Clinical Notes (Private)

**Risk Stratification:**
- Use clinical judgment to categorize patient risk
- High risk: Immediate aggressive intervention
- Moderate risk: Standard protocol with close monitoring
- Low risk: May achieve reversal with Phase 1 alone

**Patient Compliance Factors:**
- Assess readiness for change (motivational interviewing)
- Identify barriers (time, budget, support, knowledge)
- Tailor recommendations to patient's life circumstances
- Regular check-ins improve accountability

**Treatment Personalization:**
- Not all patients need all therapies
- Start with foundation, add therapies based on response
- Budget-conscious patients: Focus on lifestyle + core supplements first
- Performance-oriented patients: May embrace advanced therapies earlier

**Follow-Up Priorities:**
1. Ensure dietary compliance (make-or-break factor)
2. Monitor energy as early indicator of response
3. Track lab improvements at 6 and 12 weeks
4. Adjust protocol based on patient feedback and results
5. Long-term: Transition to sustainable maintenance

**Billing & Documentation:**
- Document medical necessity for therapies
- Provide clear treatment rationale for insurance (if applicable)
- Transparent pricing for cash-pay services
- Offer payment plans for larger protocol investments

---

**End of Protocol**

This protocol is a living document and will be updated based on emerging evidence, clinical outcomes, and patient feedback.

For questions or protocol customization, consult with Expand Health medical team.
